This Company is On A Mission to Raise Credibility in Science
Credible Research Leads to Incredible Impact
November 16, 2018Established in 1925, now with headquarters and bioproduction facilities located in Manassas, Virginia and a growing facility in Gaithersburg, Maryland, ATCC is one of the oldest life science organizations in the BioHealth Capital Region. ATCC, the premier global biological materials resource and standards organization, is making a new commitment to raise credibility in science. With a new ‘Credible leads to incredible” 2020 campaign, they have committed to addressing some of the major challenges affecting credibility in biological research. Used by thousands of research organizations around the world, ATCC develops high-quality products, standards, and services to support scientific research. Their offerings range from repository-related operations, providing standard and specialized services, conducting in-house R&D, and also intellectual property management. ATCC’s unique position supporting and collaborating with the global research and scientific community also provides them with a unique opportunity to make an impact. So as life science research has seen a growing credibility crisis that restrains progress and the pace of innovation, ATCC has pledged to do something about it. Their pledge is to empower scientists with cutting-edge authentication techniques, advanced biological models, and essential resources needed to accelerate innovative research. To join ATCC on their mission to raise the standards for credibility in science, visit their career page.
The following two tabs change content below.
Over the past 8 years, Chris has grown BioBuzz into a respected brand that is recognized for its community building, networking events and news stories about the local biotech industry. In addition, he runs a Recruiting and Marketing Agency that helps companies attract top talent through a blended model that combines employer branding and marketing services together with a high powered recruiting solution.
Latest posts by Chris Frew (see all)
- Viela Bio Receives U.S. FDA Breakthrough Therapy Designation for Inebilizumab for Treatment of Neuromyelitis Optica Spectrum Disorder - April 18, 2019
- REGENXBIO Appoints Dr. Steve Pakola as Chief Medical Officer - April 17, 2019
- BioTalk Podcast – Live from the BioHealth Capital Region Forum - April 16, 2019